XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Cash Flows [Abstract]    
Cash and cash equivalents at beginning of year $ 1,499,142 $ 439,272
Cash flows from operating activities:    
Net income 1,276,703 281,547
Adjustments to reconcile net income to cash flows from operating activities:    
Depreciation and amortization 87,271 66,574
(Gain) loss on sale of business/interest in properties 0 8,400
Stock-based compensation and other 10,540 4,245
Equity in net income of unconsolidated investments (net of tax) (396,188) (62,436)
Dividends received from unconsolidated investments and nonmarketable securities 547,552 39,168
Pension and postretirement benefit 1,954 (4,250)
Pension and postretirement contributions (2,825) (3,890)
Unrealized (gain) loss on investments in marketable securities (45,732) 1,469
Deferred income taxes 14,098 27,747
Working capital changes (764,071) (219,397)
Non-cash transfer of 40% value of construction in progress of Kemerton plant to MRL 7,665 65,100
Other, net (15,987) 1,899
Net cash provided by operating activities 720,980 206,176
Cash flows from investing activities:    
Capital expenditures (415,608) (231,698)
(Purchases) sales of marketable securities, net (122,267) 3,751
Investments in equity and other corporate investments (1,133) (146)
Net cash used in investing activities (539,008) (228,093)
Cash flows from financing activities:    
Proceeds from borrowings of long-term debt and credit agreements 0 280,000
Other debt repayments, net (713) (166,615)
Dividends paid to shareholders (46,282) (45,637)
Dividends paid to noncontrolling interests (53,145) 0
Proceeds from exercise of stock options 81 419
Withholding taxes paid on stock-based compensation award distributions (18,617) (10,422)
Other 0 (126)
Net cash (used in) provided by financing activities (118,676) 57,619
Net effect of foreign exchange on cash and cash equivalents 24,296 (11,649)
Increase in cash and cash equivalents 87,592 24,053
Cash and cash equivalents at end of period $ 1,586,734 $ 463,325